ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon Print

Single-dose flu drug approved for sale in Japan

Shionogi's virus-suppressing medication to rival Tamiflu

It is hoped that Xofluza can bring down the costs of flu treatment and help control the spread of infection.

TOKYO -- A drug that suppresses replication of the flu virus with a single oral dose has been approved for sale in Japan.

Japanese drugmaker Shionogi on Friday announced that its Xofluza tablet had received approval from the Ministry of Health, Labour and Welfare.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more